13F filing recap · Q4 2022
What did Fairfax Financial Holdings buy in Q4 2022?
Reported stock-position changes between this filing and the previous one.
Stock value
$3.69B
Positions
74
Estimated turnover
2.6%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
BILSPDR Series Trust$1.70Mreported value+18.6K sharesCIXCI Financial Corp$1.64Mreported value+165.2K sharesBNBrookfield Corporation$1.57Mreported value+50.0K sharesVIVOMeridian Bioscience Inc$1.37Mreported value+41.4K sharesCRDOCredo Technology Group Holding Ltd$1.16Mreported value+87.6K sharesSWCHFSierra Wireless Inc$1.11Mreported value+38.2K sharesTGNATegna Inc$677.8Kreported value+32.0K sharesBAMBrookfield Asset Management Ltd.$360.8Kreported value+12.6K sharesGNTXGentex Corporation$267.1Kreported value+9.8K sharesFGF&G Annuities & Life, Inc.$38.1Kreported value+1.9K sharesBNREBrookfield Wealth Solutions Ltd$10.7Kreported value+343 shares